Table 3.

Response to treatment according to RECIST

Response	Crizotinib N = 56	First‐line Crizotinib N = 30	First‐line Chemotherapy N = 50	Second‐line Crizotinib N = 26
CR, n (%)	1 (1.8)	1 (3.3)	0	0
PR, n (%)	38 (67.9)	21 (70.0)	18 (36.0)	17 (65.4)
SD, n (%)	13 (23.2)	6 (20.0)	21 (42.0)	7 (26.9)
PD, n (%)	4 (7.1)	2 (6.7)	11 (22.0)	2 (7.7)
ORR, %	69.6	73.3	36.0	65.4
DCR, %	92.9	93.3	78.0	92.3

CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate.